Ipca Laboratories Limited (NSE:IPCALAB)
India
· Delayed Price · Currency is INR 1,501.90
+1.00 (0.07%)
Mar 6, 2026, 3:30 PM IST
Ipca Laboratories Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Operating Revenue | 95,045 | 89,396 | 77,050 | 62,443 | 58,298 | 54,200 | Upgrade
|
| Other Revenue | 16.3 | 16.3 | 8.4 | 37.9 | 7.1 | 7.4 | Upgrade
|
| Revenue | 95,062 | 89,412 | 77,059 | 62,481 | 58,305 | 54,207 | Upgrade
|
| Revenue Growth (YoY) | 8.93% | 16.03% | 23.33% | 7.16% | 7.56% | 16.58% | Upgrade
|
| Cost of Revenue | 31,423 | 30,815 | 28,475 | 25,229 | 22,080 | 18,965 | Upgrade
|
| Gross Profit | 63,639 | 58,598 | 48,584 | 37,252 | 36,225 | 35,242 | Upgrade
|
| Selling, General & Admin | 21,496 | 20,055 | 17,314 | 13,076 | 11,964 | 10,309 | Upgrade
|
| Other Operating Expenses | 23,245 | 21,618 | 18,412 | 14,537 | 11,374 | 9,720 | Upgrade
|
| Operating Expenses | 48,825 | 45,625 | 39,268 | 30,218 | 25,635 | 22,097 | Upgrade
|
| Operating Income | 14,814 | 12,973 | 9,316 | 7,034 | 10,591 | 13,146 | Upgrade
|
| Interest Expense | -766.4 | -843.2 | -1,373 | -450.9 | -72.4 | -86.1 | Upgrade
|
| Interest & Investment Income | 351.2 | 351.2 | 629.3 | 793.5 | 341.7 | 369.5 | Upgrade
|
| Earnings From Equity Investments | -66.7 | -22.9 | -62.9 | -129.4 | -211.6 | -77 | Upgrade
|
| Currency Exchange Gain (Loss) | 330.1 | 330.1 | 329.5 | -315.1 | 307.9 | 413 | Upgrade
|
| Other Non Operating Income (Expenses) | 197.9 | 60.6 | 46.9 | 110.1 | 70.4 | 133.1 | Upgrade
|
| EBT Excluding Unusual Items | 14,860 | 12,849 | 8,886 | 7,042 | 11,027 | 13,898 | Upgrade
|
| Merger & Restructuring Charges | - | - | -390.4 | - | - | - | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -158.4 | Upgrade
|
| Gain (Loss) on Sale of Investments | 466.2 | 466.2 | 547.1 | 149.7 | 232.9 | 101.4 | Upgrade
|
| Gain (Loss) on Sale of Assets | 27.6 | 27.6 | 6.2 | 160.5 | -0.3 | - | Upgrade
|
| Asset Writedown | -3.4 | -3.4 | 2.1 | -28.4 | -113.6 | -28.6 | Upgrade
|
| Other Unusual Items | -2,457 | -2,051 | -687.1 | - | - | - | Upgrade
|
| Pretax Income | 12,894 | 11,289 | 8,364 | 7,324 | 11,146 | 13,813 | Upgrade
|
| Income Tax Expense | 3,483 | 3,436 | 3,135 | 2,534 | 2,248 | 2,401 | Upgrade
|
| Earnings From Continuing Operations | 9,411 | 7,852 | 5,229 | 4,790 | 8,898 | 11,411 | Upgrade
|
| Minority Interest in Earnings | -312.1 | -475.6 | 244.3 | -76.7 | -57.1 | -11.3 | Upgrade
|
| Net Income | 9,099 | 7,377 | 5,474 | 4,713 | 8,841 | 11,400 | Upgrade
|
| Net Income to Common | 9,099 | 7,377 | 5,474 | 4,713 | 8,841 | 11,400 | Upgrade
|
| Net Income Growth | 24.73% | 34.77% | 16.13% | -46.69% | -22.45% | 88.02% | Upgrade
|
| Shares Outstanding (Basic) | 251 | 254 | 254 | 254 | 254 | 253 | Upgrade
|
| Shares Outstanding (Diluted) | 251 | 254 | 254 | 254 | 254 | 253 | Upgrade
|
| Shares Change (YoY) | -1.02% | - | - | - | 0.17% | 0.16% | Upgrade
|
| EPS (Basic) | 36.22 | 29.08 | 21.57 | 18.58 | 34.85 | 45.01 | Upgrade
|
| EPS (Diluted) | 36.22 | 29.08 | 21.57 | 18.58 | 34.85 | 45.01 | Upgrade
|
| EPS Growth | 26.01% | 34.77% | 16.13% | -46.69% | -22.58% | 87.73% | Upgrade
|
| Free Cash Flow | - | 5,458 | 5,334 | 3,113 | 3,771 | 7,286 | Upgrade
|
| Free Cash Flow Per Share | - | 21.51 | 21.02 | 12.27 | 14.87 | 28.77 | Upgrade
|
| Dividend Per Share | 2.000 | 4.000 | 4.000 | 4.000 | 4.000 | 4.000 | Upgrade
|
| Dividend Growth | -50.00% | - | - | - | - | 60.00% | Upgrade
|
| Gross Margin | 66.94% | 65.54% | 63.05% | 59.62% | 62.13% | 65.01% | Upgrade
|
| Operating Margin | 15.58% | 14.51% | 12.09% | 11.26% | 18.16% | 24.25% | Upgrade
|
| Profit Margin | 9.57% | 8.25% | 7.10% | 7.54% | 15.16% | 21.03% | Upgrade
|
| Free Cash Flow Margin | - | 6.10% | 6.92% | 4.98% | 6.47% | 13.44% | Upgrade
|
| EBITDA | 18,784 | 16,668 | 12,644 | 9,460 | 12,749 | 15,073 | Upgrade
|
| EBITDA Margin | 19.76% | 18.64% | 16.41% | 15.14% | 21.87% | 27.81% | Upgrade
|
| D&A For EBITDA | 3,970 | 3,695 | 3,328 | 2,427 | 2,158 | 1,927 | Upgrade
|
| EBIT | 14,814 | 12,973 | 9,316 | 7,034 | 10,591 | 13,146 | Upgrade
|
| EBIT Margin | 15.58% | 14.51% | 12.09% | 11.26% | 18.16% | 24.25% | Upgrade
|
| Effective Tax Rate | 27.01% | 30.44% | 37.48% | 34.59% | 20.17% | 17.39% | Upgrade
|
| Revenue as Reported | 96,111 | 90,324 | 78,298 | 63,699 | 58,964 | 54,828 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.